Photodynamic therapy of non-resectable cholangio carcinoma - A randomized prospective study - First results

被引：0
|
作者：
Ortner, MAE
Berr, F
Liebetruth, J
Giesse, A
Caca, K
Huster, D
Moessner, J
Lochs, H
机构：
[1] Humboldt Univ, Charite CCM, Dept Gastroenterol, Berlin, Germany
[2] Univ Leipzig, Dept Med 2, Leipzig, Germany
[3] Humboldt Univ, Charite CCM, Dept Surg, Berlin, Germany
[4] Humboldt Univ, Charite CCM, Berlin, Germany
来源：
GASTROINTESTINAL ENDOSCOPY | 2001年 / 53卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3321
引用
收藏
页码：AB85 / AB85
页数：1
相关论文
共 50 条
  • [21] Radiotherapeutic strategies in the multimodality approach of resectable and non-resectable pancreatic carcinoma
    Wiegel, T
    Runkel, N
    Frommhold, H
    Rübe, C
    Hinkelbein, W
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (07) : 299 - 306
  • [22] Use of electrolysis for the treatment of non-resectable hepatocellular carcinoma
    Fosh, BG
    Finch, JG
    Anthony, AA
    Lea, MM
    Wong, SK
    Black, CL
    Maddern, GJ
    ANZ JOURNAL OF SURGERY, 2003, 73 (12) : 1068 - 1070
  • [23] Non-randomised comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: A prospective study
    Ruers, TJM
    Joosten, JJ
    Wiering, B
    Langenhoff, B
    Dekker, H
    Oyen, T
    Wobbes, W
    Punt, CJA
    Krabbe, PFM
    ANNALS OF ONCOLOGY, 2006, 17
  • [24] ARTERIAL CHEMOTHERAPY AND TRANSCATHETER ARTERIAL EMBOLIZATION THERAPY FOR NON-RESECTABLE HEPATOCELLULAR-CARCINOMA
    HIRAI, K
    KAWAZOE, Y
    YAMASHITA, K
    AOKI, Y
    FUJIMOTO, T
    SAKAI, T
    MAJIMA, Y
    ABE, M
    TANIKAWA, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 : S37 - S41
  • [25] Non-randomised comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases; A prospective study
    Ruers, T.
    Joosten, J.
    Wiering, B.
    Dekker, H.
    Oyen, W.
    Wobbes, T.
    Krabbe, P.
    Punt, K.
    ANNALS OF ONCOLOGY, 2006, 17 : 85 - 85
  • [26] Multimodality combination therapy for non-resectable biliary malignancies
    Bruha, R
    Petrtyl, J
    Marecek, Z
    Kubecova, M
    Urbanek, P
    Kalab, M
    Chodounsky, Z
    JOURNAL OF HEPATOLOGY, 2001, 34 : 185 - 185
  • [27] Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma
    Saiag, Philippe
    Blom, Astrid
    LANCET, 2022, 400 (10357): : 976 - 977
  • [28] Treatment of Patients with non-resectable Merkel Cell Carcinoma with Pembrolizumab
    Leyh, J.
    Papapanagiotou, M.
    Franklin, C.
    Hoefer, T.
    Herz, S.
    Meyenburg, S.
    Ugurel, S.
    Schadendorf, D.
    Roesch, A.
    Schilling, B.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 21 - 21
  • [29] First-line Therapy for Patients with advanced or non-resectable Carcinoma Immuno-oncologic Combination Therapy: New Option for unfit Patients
    Ruedesheim, Sabine M.
    VISCERAL MEDICINE, 2024, 40 (02) : 102 - 102
  • [30] Factors predicting survival in patients with non-resectable hepatocellular carcinoma
    Siddiqui, A.
    Abbas, Z.
    Khan, Z.
    Luck, N.
    Hassan, M.
    Mirza, R.
    Naqvi, A.
    Rizvi, A. H.
    LIVER INTERNATIONAL, 2006, 26 : 64 - 64
12345